Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134160) titled 'A multicenter,phase ?,randomized open-label clinical study of BL-B01D1 versus chemotherapy physician-selected in recurrent/ metastatic nasopharyngeal carcinoma patients treated with PD-1/L1 monoclonal' on Oct. 11.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Sun Yat-sen University Cancer Center
Condition:
Recurrent or metastatic nasopharyngeal carcinoma
Intervention:
Experimental group:BL-B01D1 for injection was administered by intravenous drip
Recruitment Status: Not Recruiting
Phase: 3
Date of First Enrollment: 2023-12-04
Target Sample Size: Experimental group:184;Contr...